BioInformatics Inc. acquires IMV Publishing and creates the Science and Medicine Group
BioInformatics Inc., the leading market research firm supporting the analytical instrumentation and life science industries, and owner of The Science Advisory Board®, is pleased to announce the acquisition of IMV Publishing www.imvinfo.com. This latest acquisition by BioInformatics Inc. creates an integrated business information and media group delivering high-value content to the market's buyers and sellers using a broad range of media formats. The companies share deep expertise in the areas of producing market intelligence, generating premium content, profiling customers and delivering targeted marketing to large, curated online communities of scientific and medical professionals.
Founded in 1977, IMV is a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets. With offices in Chicago, Tucson, and San Francisco, IMV offers a broad range of market research products and reports and media properties including Aunt Minnie www.auntminnie.com the leader in online medical imaging news and radiology CME and DrBicuspid www.drbicuspid.com the fastest growing dental news and continuing education (CE) digital property.
The assets of IMV will be combined with existing capabilities including BioInfo Market Research www.bioinfoinc.com, The Science Advisory Board ® www.scienceboard.com, Strategic Directions International (SDI) www.strategic-directions.com (creator of the SDi Global Report), and Instrument Business Outlookwww.instrumentbusinessoutlook.com a bi-weekly publication subscribed to and read by senior executives in the analytical instrument market.
Together all companies and assets will be managed and integrated under the newly created Science and Medicine Group www.scienceandmedicinegroup.com which will be headquartered in Arlington Virginia and have services in business intelligence / market research, digital media and marketing, publishing, and job boards for scientists, lab managers, dentists, and radiologists.
"Over the next 5 to 10 years we see a world where instruments and diagnostics -- including analytical, imaging, and clinical -- will converge to lead a precision medicine revolution," said Craig Overpeck, CEO of Science and Medicine Group. "We are putting a stake at the intersection of science, medicine, and technology to help guide companies with transformative information and media products and services for converging markets that will make a difference in the lives of billions of people for the next century."
With the combined entities, Science and Medicine Group will become one of the top 50 full service market research companies in the world by exclusively focusing on helping science and medicine businesses grow.
Broad Oak Capital Partners (Bethesda, MD) provided financing to facilitate the transaction.
About Science and Medicine Group
Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Our clients, including some of the top Fortune 500 companies in the world, use our business intelligence, market research and publications, and marketing platforms to grow their businesses globally.